Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
Shanghai Fosun Pharmaceutical Group Co Ltd
EPS (Diluted)
Shanghai Fosun Pharmaceutical Group Co Ltd
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
|
EPS (Diluted)
¥0
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
0%
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
EPS (Diluted)
¥0
|
CAGR 3-Years
7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
EPS (Diluted)
¥4
|
CAGR 3-Years
19%
|
CAGR 5-Years
20%
|
CAGR 10-Years
21%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
EPS (Diluted)
¥0
|
CAGR 3-Years
-12%
|
CAGR 5-Years
1%
|
CAGR 10-Years
13%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
EPS (Diluted)
¥2
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
0%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
EPS (Diluted)
-¥1
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Shanghai Fosun Pharmaceutical Group Co Ltd's EPS (Diluted)?
EPS (Diluted)
0.8
CNY
Based on the financial report for Mar 31, 2024, Shanghai Fosun Pharmaceutical Group Co Ltd's EPS (Diluted) amounts to 0.8 CNY.
What is Shanghai Fosun Pharmaceutical Group Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
0%
Over the last year, the EPS (Diluted) growth was -53%. The average annual EPS (Diluted) growth rates for Shanghai Fosun Pharmaceutical Group Co Ltd have been -21% over the past three years , -7% over the past five years .